Surrogate cardiovascular outcomes with sodium-glucose co-transporter-2 inhibitors in women: An updated meta-analysis

The burden of cardiovascular disease morbidity and mortality among women with type 2 diabetes mellitus remains high, despite the improvement in therapeutic management over the recent years. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have revolutionized treatment of cardiovascular disease in...

Descripción completa

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios, Papadopoulos, Christodoulos, Doumas, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961258/
https://www.ncbi.nlm.nih.gov/pubmed/33714400
http://dx.doi.org/10.1016/j.ihj.2020.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961258/
https://www.ncbi.nlm.nih.gov/pubmed/33714400
http://dx.doi.org/10.1016/j.ihj.2020.12.012

Ejemplares similares